HOME >> BIOLOGY >> NEWS
AAAS CEO Alan I. Leshner welcomes proposed Washington state legislation on stem cell research

WASHINGTON, D.C.-AAAS has welcomed efforts by Washington state legislators to pass a bill banning reproductive cloning in the state while allowing research on human embryonic stem cells.

In letters sent to two sponsors of the bill, Alan I. Leshner, the chief executive officer of AAAS and executive publisher of the journal Science, reaffirmed the association's position that cloning to extract stem cells from early-stage human embryos for research purposes "holds great promise." But he also noted that "the benefits will only be realized through carefully designed research" that is subject to appropriate ethical and legal oversight. And he reiterated that AAAS has endorsed a legal ban on any efforts to clone human embryos to produce babies.

Leshner's letter was faxed Monday 28 March 28 2005 as a committee of the Washington State Senate holds a hearing on the bill, which already has been approved by the state's House of Representatives. The letter was sent to state Rep. Shay Schual-Berke, a physician and sponsor of the bill in the House, and state Sen. Jeanne Kohl-Welles, a co-sponsor in the Senate who has a Ph.D. in sociology. Both are Democrats.

The bill includes some specific ethical guidelines, such as the patient's right to full disclosure and civil penalties for reproductive cloning.

Legislators in several states, including Maryland, have attempted to follow the lead of California in backing stem cell research that President George W. Bush restricted at the federal level in 2001. In Congress, the House leadership reportedly has agreed to allow a floor vote this session on a proposal to ease the federal restrictions and allow study of newer stem cell lines derived from embryos discarded by fertility clinics.

[For more information, read the full letter. ]


'"/>


29-Mar-2005


Page: 1

Related biology news :

1. Statement from Dr. Alan I. Leshner, CEO of AAAS, on the Kansas State Board of Education vote
2. AAAS CEO Alan I. Leshner urges US to continue collecting job data on women workers
3. AAAS CEO Alan I. Leshner registers strong concerns over suppression of science films
4. AAAS CEO Alan I. Leshner statement on the UN cloning debate
5. National Inventors Hall of Fame welcomes 2005 inductees
6. BioMed Central welcomes the new National Institutes of Health public access policy
7. Telemedicine initiative for sub-Saharan Africa: Pilot projects proposed
8. Major initiative proposed to address amphibian crisis
9. AIDS research agenda proposed
10. New model of p53 regulation proposed that suggests novel anticancer strategy
11. Mechanism proposed for link between RU-486 and fatal infections

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/13/2016)... 13, 2016  IMPOWER physicians supporting Medicaid patients in ... new clinical standard in telehealth thanks to a new ... higi platform, IMPOWER patients can routinely track key health ... mass index, and, when they opt in, share them ... to a local retail location at no cost. By ...
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... TORONTO , June 23, 2016 /PRNewswire/ - ... Ontario biotechnology company, Propellon ... the development and commercialization of a portfolio of ... cancers. Epigenetic targets such as WDR5 represent an ... contribute significantly in precision medicine for cancer patients. ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
(Date:6/23/2016)... Pleasant Prairie, WI (PRWEB) , ... June 23, ... ... sciences consultancy focused on quality, regulatory and technical consulting, provides a free ... webinar is presented on July 13, 2016 at 12pm CT at no charge. ...
Breaking Biology Technology:
Cached News: